Sterling Capital Management LLC Biomarin Pharmaceutical Inc Transaction History
Sterling Capital Management LLC
- $6.45 Trillion
- Q1 2025
A detailed history of Sterling Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 10,498 shares of BMRN stock, worth $629,145. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,498
Previous 11,192
6.2%
Holding current value
$629,145
Previous $736 Million
0.88%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.14 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.07 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$896 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$647 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...